Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
NCT03984747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2025-03-18
Summary
This is a multi-center prospective study designed to collect blood samples from transplant patients in order to improve Natera's method for determining allograft rejection status using the donor-derived cell-free DNA analysis, called Prospera.
Conditions
- Transplant Rejection
- Allograft Rejection
- Complications
Sponsors & Collaborators
-
Natera, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-14
- Primary Completion
- 2024-08-23
- Completion
- 2024-08-23
Countries
- United States
Study Locations
More Related Trials
-
Donor-derived Cell Free DNA as a New Biomarker in Cardiac Acute Rejection
NCT04973943 ·Status: UNKNOWN
-
Blood Biomarkers in Pediatric Kidney Transplant Recipients
NCT05477082 ·Status: ACTIVE_NOT_RECRUITING
-
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation
NCT02424227 ·Status: UNKNOWN
-
Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)
NCT02109575 ·Status: COMPLETED
-
Donor Derived Cell-free DNA and Rejection of Kidney Allografts
NCT05995379 ·Status: COMPLETED
-
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection
NCT04897438 ·Status: COMPLETED ·Phase: NA
-
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
NCT05084768 ·Status: RECRUITING
-
Biomarkers for Diagnosis, Prognosis, and Targeted Therapy After Heart Transplantation
NCT06064123 ·Status: RECRUITING
-
Next Generation Sequencing to Detect Acute Rejection in Lung Transplant Patients.
NCT05260372 ·Status: UNKNOWN
-
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
NCT07006831 ·Status: RECRUITING
-
Cf-DNA Assay During Treatment of Acute Rejection
NCT04019353 ·Status: COMPLETED
-
Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
NCT05811468 ·Status: WITHDRAWN
-
Genome Transplant Dynamics: Non-invasive Sequencing-based Diagnosis of Rejection
NCT01985412 ·Status: COMPLETED
-
Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection
NCT06351488 ·Status: RECRUITING
-
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
NCT04855422 ·Status: ACTIVE_NOT_RECRUITING
-
A New Biomarker for the Non-invasive Diagnosis of Rejection After Heart Transplantation
NCT03477383 ·Status: COMPLETED
-
Longitudinal Study of Cell Free DNA in Lung Transplant
NCT04234919 ·Status: COMPLETED
-
Donor Specific HLA Alloantibodies in Liver Transplantation
NCT02784080 ·Status: ACTIVE_NOT_RECRUITING
-
TransplantLines: the Transplantation Biobank
NCT03272841 ·Status: UNKNOWN
-
Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
NCT06910527 ·Status: RECRUITING
-
Rejection Diagnosis in Kidney Transplants Patients
NCT03582436 ·Status: COMPLETED
-
Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response
NCT03430414 ·Status: UNKNOWN
-
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
NCT06399302 ·Status: RECRUITING
-
Trifecta-Kidney cfDNA-MMDx Study
NCT04239703 ·Status: RECRUITING
-
SRDK0921_ Analytical Performance Study
NCT05747274 ·Status: COMPLETED